COVID-19-induced toxic epidermal necrolysis

Clin Exp Dermatol. 2021 Jul;46(5):927-929. doi: 10.1111/ced.14574. Epub 2021 Feb 19.

Authors

I Narang¹, A P Panthagani¹, M Lewis², B Chohan³, A Ferguson¹, R Nambi¹

Affiliations

¹ Department of, Department of, Dermatology, University Hospitals of Derby and Burton, Derby, UK.
² Department of, Palliative Medicine, University Hospitals of Derby and Burton, Derby, UK.
³ Department of, Pathology, University Hospitals of Derby and Burton, Derby, UK.

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adrenal Cortex Hormones / therapeutic use
Androstadienes / therapeutic use
Aromatase Inhibitors / therapeutic use
Body Surface Area
Bone Neoplasms / complications
Bone Neoplasms / drug therapy
Bone Neoplasms / secondary
Brain Neoplasms / complications
Brain Neoplasms / drug therapy
Brain Neoplasms / secondary
Breast Neoplasms / complications
Breast Neoplasms / drug therapy
Breast Neoplasms / pathology
COVID-19 / complications
COVID-19 / diagnosis*
Dexamethasone / therapeutic use
Emollients / therapeutic use
Female
Hospitalization
Humans
Liver Neoplasms / complications
Liver Neoplasms / drug therapy
Liver Neoplasms / secondary
Middle Aged
Palliative Care
SARS-CoV-2
Stevens-Johnson Syndrome / diagnosis*
Stevens-Johnson Syndrome / drug therapy
Stevens-Johnson Syndrome / etiology
Stevens-Johnson Syndrome / pathology

Substances

Adrenal Cortex Hormones
Androstadienes
Aromatase Inhibitors
Emollients
Dexamethasone
exemestane